Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Intelligent Bio Solutions Inc. (INBS:NASDAQ), powered by AI.
Intelligent Bio Solutions Inc. is currently trading at $3.14. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Intelligent Bio Solutions Inc. on Alpha Lenz.
Intelligent Bio Solutions Inc.'s P/E ratio is -0.2.
“Intelligent Bio Solutions Inc. trades at a P/E of -0.2 (undervalued) with modest ROE of -186.6%.”
Ask for details →Intelligent Bio Solutions Inc. is a pioneering company in the biotechnology and medical technology sectors. The company's primary function is to advance health care solutions through the development of innovative, diagnostic technologies that focus on improving patient outcomes. It operates predominantly in the biosensor technology space, leveraging cutting-edge research and development to create highly sensitive diagnostic tools. Intelligent Bio Solutions Inc. plays a significant role in enhancing healthcare efficiency by offering rapid, accurate, and cost-effective diagnostic solutions. This is particularly impactful in areas such as disease management and healthcare delivery, where time-sensitive results are critical. The company collaborates across various healthcare institutions, contributing to sectors like clinical diagnostics, patient monitoring, and personalized medicine. By consistently driving technological advancements, Intelligent Bio Solutions Inc. helps to redefine standards in medical diagnostics, positioning itself as an integral player in transforming healthcare systems worldwide through innovative biosensor solutions.
“Intelligent Bio Solutions Inc. trades at a P/E of -0.2 (undervalued) with modest ROE of -186.6%.”
Ask for details →Intelligent Bio Solutions Inc. (ticker: INBS) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 53 employees. Market cap is $2M.
The current price is $3.14 with a P/E ratio of -0.16x and P/B of 0.55x.
ROE is -186.64% and operating margin is -341.50%. Annual revenue is $3M.